Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS)

CNY 13.44

(-0.07%)

Market Cap (In CNY)

21.71 Billion

Revenue (In CNY)

3.93 Billion

Net Income (In CNY)

-189.44 Million

Avg. Volume

5.46 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
10.45-16.01
PE
-
EPS
-
Beta Value
0.492
ISIN
CNE100002WP3
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Ms. Wu Guiping
Employee Count
-
Website
https://www.nkf-pharma.com
Ipo Date
2017-07-19
Details
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd manufactures and sells heparin sodium and low molecular weight heparin products for pharmaceutical companies in the People's Republic of China. It offers enoxaparin sodium, dalteparin sodium, and naqu heparin calcium injections. The company also exports its products primarily to the European and American countries. The company was founded in 2000 and is based in Nanjing, the People's Republic of China.